Senator Ron Johnson Investigates FDA Over Drug Rejections Impacting Rare Disease Treatments
Senator Ron Johnson, a Republican from Wisconsin, is conducting an investigation into the U.S. Food and Drug Administration (FDA) regarding its handling of drug approvals for rare disease treatments. The investigation stems from concerns about the FDA's alleged mismanagement and flawed drug review processes, which have reportedly deterred investments in innovative, life-saving cures. This scrutiny comes amid broader criticisms of the FDA's decision-making under Commissioner Marty Makary, whose tenure has been marked by controversial decisions on drugs and vaccines. The agency has faced backlash for its unpredictable practices, which some argue have undermined public trust and opened the door to international competitors like China. Representative Darin LaHood, a Republican from Illinois, has echoed these concerns, emphasizing the need for a more efficient FDA to maintain U.S. competitiveness in the pharmaceutical industry. 
